tizanidine and cyp1a2 inhibitors
Published 3 years ago • 580 plays • Length 46:19Download video MP4
Download video MP3
Similar videos
-
53:33
pbpk modeling of tizanidine systemic exposure by cyp1a2 modulation: impact of ddis & smoking
-
12:22
tizanidine pharmacology
-
46:29
colchicine cyp3a4 / pgp inhibitors decision support webinar discussion
-
21:13
fda approves clonidine xr: first liquid non-stimulant for adhd
-
8:31
managing a case of antipsychotic-induced weight gain
-
![are you a slow metabolizer of caffeine? let's find out. [2 methods]](https://i.ytimg.com/vi/JghrWCpybIQ/mqdefault.jpg)
4:09
are you a slow metabolizer of caffeine? let's find out. [2 methods]
-
57:45
using existing cerner tools to monitor and improve drug drug interaction warnings
-
4:20
tyrosine kinase inhibitors (tkis) - imatinib (gleevec) - pharmacology - cml and all
-
8:19
drug-drug interaction between emtricitabine/tenofovir alafenamide (ftc/taf)..., akarin hiransuthikul
-
3:50
first- and second-generation antipsychotics for managing explosive behavior
-
4:03
kinin b1 receptor, angiotensin i-converting enzyme inhibition, and gout
-
2:16
pharmacogenomics & cyp1a2
-
1:01
does genetic variability in the cyp1a2 gene modify caffeine's effects on anaerobic performance
-
5:51
distinction between tizanidine and metaxalone
-
12:21
brandl's basics: protein synthesis inhibitors 2 - adverse effects and spectrum of activity
-
2:42
d2 receptor-disc1 complex and antipsychotic effects
-
6:14
the daily debate - sglt-2 inhibitors and t1d
-
4:27
effect of cyp2c19 genetic variation on antidepressant-related sleep disturbance: uk biobank study
-
3:34
cpic guideline for serotonin reuptake inhibitors and cyp2d6, htr2a and slc6a4 - no recommendations
-
5:51
covid-19: should we continue using immunomodulatory drugs to treat our patients?